Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adecoagro SA (AGRO) vs Eli Lilly And Co (LLY) Price & Performance

Adecoagro SATrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Adecoagro SA vs Eli Lilly And Co — how do they compare? Adecoagro SA trades at $9.7 (market cap $1.36B), while Eli Lilly And Co trades at $1,208.07 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 794.1× Adecoagro SA's market cap, and Adecoagro SA pays the higher dividend (3.15%). Which is the better fit depends on your goals.

AGROLLY
Market Cap
$1.36B$1.08T
Sector
TechnologyHealth
52-Week High
$15.25$1.24K
52-Week Low
$7.13$639.43
Enterprise Value
$3.39B$1.13T
Dividend Yield
3.15%0.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Adecoagro SA

No Aura AI signal available yet.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,231.58, up 3.87% in the past 24 hours, reflecting strong momentum near its 52-week high. The stock exhibits bullish technical signals with robust fundamentals, including 48% revenue growth in Q2 2026 and a net income margin of 33.53%. Recent news highlights legal actions against black-market drug sales and positive analyst sentiment following earnings beats.

Outlook remains positive with a consensus price target of $1,380, though high valuation ratios (P/E 40.79) and regulatory risks pose challenges. Earnings growth and pipeline advancements, like retatrutide, drive upside potential, but investors should monitor competitive pressures and execution risks.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Adecoagro SA

Adecoagro is a South American agricultural company. It operates a diversified business including farming crops, rice, and dairy, as well as producing sugar, ethanol, and renewable energy from its industrial facilities.

Read more on AGRO

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY